CNTX
Price
$0.81
Change
+$0.02 (+2.53%)
Updated
Feb 21 closing price
Capitalization
61.05M
24 days until earnings call
ELVN
Price
$21.80
Change
+$0.33 (+1.54%)
Updated
Feb 21 closing price
Capitalization
1.07B
18 days until earnings call
Ad is loading...

CNTX vs ELVN

Header iconCNTX vs ELVN Comparison
Open Charts CNTX vs ELVNBanner chart's image
Context Therapeutics
Price$0.81
Change+$0.02 (+2.53%)
Volume$90.03K
Capitalization61.05M
Enliven Therapeutics
Price$21.80
Change+$0.33 (+1.54%)
Volume$169.97K
Capitalization1.07B
CNTX vs ELVN Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTX vs. ELVN commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and ELVN is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CNTX: $0.81 vs. ELVN: $21.80)
Brand notoriety: CNTX and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 15% vs. ELVN: 72%
Market capitalization -- CNTX: $61.05M vs. ELVN: $1.07B
CNTX [@Biotechnology] is valued at $61.05M. ELVN’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileELVN’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • ELVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ELVN is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 5 TA indicator(s) are bullish while ELVN’s TA Score has 2 bullish TA indicator(s).

  • CNTX’s TA Score: 5 bullish, 3 bearish.
  • ELVN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than ELVN.

Price Growth

CNTX (@Biotechnology) experienced а -0.93% price change this week, while ELVN (@Biotechnology) price change was +0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CNTX is expected to report earnings on May 07, 2025.

ELVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.07B) has a higher market cap than CNTX($61M). ELVN YTD gains are higher at: -3.111 vs. CNTX (-22.476). CNTX has higher annual earnings (EBITDA): -32.54M vs. ELVN (-100.07M). ELVN has more cash in the bank: 292M vs. CNTX (84.8M). ELVN has less debt than CNTX: ELVN (85K) vs CNTX (244K). CNTX (0) and ELVN (0) have equivalent revenues.
CNTXELVNCNTX / ELVN
Capitalization61M1.07B6%
EBITDA-32.54M-100.07M33%
Gain YTD-22.476-3.111722%
P/E RatioN/AN/A-
Revenue00-
Total Cash84.8M292M29%
Total Debt244K85K287%
TECHNICAL ANALYSIS
Technical Analysis
CNTXELVN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIESX18.51-0.12
-0.64%
Franklin International Equity IS
ARRZX13.54-0.17
-1.24%
AMG River Road Focused Absolute Value Z
CGTRX10.13-0.22
-2.13%
Columbia Select Large Cap Growth Inst2
MLRRX11.26-0.26
-2.26%
NYLI Winslow Large Cap Growth Class R1
MBCSX23.67-0.57
-2.35%
MassMutual Blue Chip Growth R5

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+3.04%
FATE - CNTX
30%
Poorly correlated
-8.09%
DSGN - CNTX
29%
Poorly correlated
-2.00%
CMMB - CNTX
29%
Poorly correlated
-3.39%
HRMY - CNTX
27%
Poorly correlated
-0.95%
ELVN - CNTX
26%
Poorly correlated
+1.54%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+1.54%
CRNX - ELVN
49%
Loosely correlated
+1.63%
OCEA - ELVN
48%
Loosely correlated
-9.12%
SER - ELVN
37%
Loosely correlated
-3.27%
ACLX - ELVN
36%
Loosely correlated
-2.83%
ERAS - ELVN
35%
Loosely correlated
-3.42%
More